Clinical Trial Type: Colorectal

Name of this trial: Origami-2  What type of cancer is this for? Colorectal Cancer  Who is this trial for? Patients with Unresectable or Metastatic Left-sided Colorectal Cancer  What biomarkers are involved? KRAS/NRAS and BRAF Wild-type  What is the National Clinical Trial #? NCT06662786 Brief summary of this trial: Randomized, Open-label Phase 3 Study of Amivantamab